Related references
Note: Only part of the references are listed.Drug susceptibility testing and mortality in patients treated for tuberculosis in high-burden countries: a multicentre cohort study
Kathrin Zurcher et al.
LANCET INFECTIOUS DISEASES (2019)
A Trial of a Shorter Regimen for Rifampin-Resistant Tuberculosis
Andrew J. Nunn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Global burden of latent multidrug-resistant tuberculosis: trends and estimates based on mathematical modelling
Gwenan M. Knight et al.
LANCET INFECTIOUS DISEASES (2019)
Transmissibility and potential for disease progression of drug resistant Mycobacterium tuberculosis: prospective cohort study
Mercedes C. Becerra et al.
BMJ-BRITISH MEDICAL JOURNAL (2019)
Projecting the impact of variable MDR-TB transmission efficiency on long-term epidemic trends in South Africa and Vietnam
Phillip P. Salvatore et al.
SCIENTIFIC REPORTS (2019)
Drug-resistant tuberculosis: An update on disease burden, diagnosis and treatment
Christoph Lange et al.
RESPIROLOGY (2018)
Delay before drug susceptibility testing among patients with presumptive multidrug-resistant tuberculosis in Gujarat, India
Hemant Deepak Shewade et al.
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2018)
Whole-Genome Sequencing of Mycobacterium tuberculosis Provides Insight into the Evolution and Genetic Composition of Drug-Resistant Tuberculosis in Belarus
Kurt R. Wollenberg et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2017)
Expected effects of adopting a 9 month regimen for multidrug-resistant tuberculosis: a population modelling analysis
Emily A. Kendall et al.
LANCET RESPIRATORY MEDICINE (2017)
MDR-TB treatment as prevention: The projected population-level impact of expanded treatment for multidrug-resistant tuberculosis
Emily A. Kendall et al.
PLOS ONE (2017)
Bedaquiline in the treatment of multidrug- and extensively drug-resistant tuberculosis
Alexander S. Pym et al.
EUROPEAN RESPIRATORY JOURNAL (2016)
Modelling the effect of short-course multidrug-resistant tuberculosis treatment in Karakalpakstan, Uzbekistan
James M. Trauer et al.
BMC MEDICINE (2016)
Ending tuberculosis by 2030: can we do it?
A. B. Suthar et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2016)
High effectiveness of a 12-month regimen for MDR-TB patients in Cameroon
C. Kuaban et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2015)
Acquired Resistance to Bedaquiline and Delamanid in Therapy for Tuberculosis
Guido V. Bloemberg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
National tuberculosis prevalence surveys in Asia, 1990-2012: an overview of results and lessons learned
Ikushi Onozaki et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2015)
Burden of transmitted multidrug resistance in epidemics of tuberculosis: a transmission modelling analysis
Emily A. Kendall et al.
LANCET RESPIRATORY MEDICINE (2015)
The Temporal Dynamics of Relapse and Reinfection Tuberculosis After Successful Treatment: A Retrospective Cohort Study
Florian M. Marx et al.
CLINICAL INFECTIOUS DISEASES (2014)
Acquired Rifampicin Resistance in Thrice-Weekly Antituberculosis Therapy: Impact of HIV and Antiretroviral Therapy
Gopalan Narendran et al.
CLINICAL INFECTIOUS DISEASES (2014)
Successful '9-month Bangladesh regimen' for multidrug-resistant tuberculosis among over 500 consecutive patients
K. J. M. Aung et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2014)
High cure rate with standardised short-course multidrug-resistant tuberculosis treatment in Niger: no relapses
A. Piubello et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2014)
Evaluation of a standardized treatment regimen of anti-tuberculosis drugs for patients with multi-drug-resistant tuberculosis (STREAM): study protocol for a randomized controlled trial
Andrew J. Nunn et al.
TRIALS (2014)
Aggressive Regimens for Multidrug-Resistant Tuberculosis Reduce Recurrence
Molly F. Franke et al.
CLINICAL INFECTIOUS DISEASES (2013)
Contact investigation for tuberculosis: a systematic review and meta-analysis
Gregory J. Fox et al.
EUROPEAN RESPIRATORY JOURNAL (2013)
The impact of HIV and ART on recurrent tuberculosis in a sub-Saharan setting
Rein M. G. J. Houben et al.
AIDS (2012)
Delamanid for Multidrug-Resistant Pulmonary Tuberculosis
Maria Tarcela Gler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Revised Category II Regimen as an Alternative Strategy for Retreatment of Category I Regimen Failure and Irregular Treatment Cases
Payam Tabarsi et al.
AMERICAN JOURNAL OF THERAPEUTICS (2011)
Natural History of Tuberculosis: Duration and Fatality of Untreated Pulmonary Tuberculosis in HIV Negative Patients: A Systematic Review
Edine W. Tiemersma et al.
PLOS ONE (2011)
Revisiting Rates of Reactivation Tuberculosis A Population-based Approach
C. Robert Horsburgh et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2010)
Recurrence after Treatment for Pulmonary Multidrug-Resistant Tuberculosis
Mercedes C. Becerra et al.
CLINICAL INFECTIOUS DISEASES (2010)
Solving Differential Equations in R: Package deSolve
Karline Soetaert et al.
JOURNAL OF STATISTICAL SOFTWARE (2010)
Follow-Up of Patients with Multidrug Resistant Tuberculosis Four Years after Standardized First-Line Drug Treatment
Guang Xue He et al.
PLOS ONE (2010)
Epidemiology of tuberculosis in a high HIV prevalence population provided with enhanced diagnosis of symptomatic disease
Elizabeth L. Corbett et al.
PLOS MEDICINE (2007)
Criteria for the control of drug-resistant tuberculosis
C Dye et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
